Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $17.23 -0.81%
EPS Growth %: +17.6%
Financial Fact:
Gross margin: 4.69M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +17.6%
Financial Fact:
Gross margin: 4.69M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q2 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $58.88 million versus the consensus estimate of $49.4 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- MoveSmart Rentals Opens Toronto Branch, Expanding Its Canadian Leasing Operations
- Boeing wins $2 billion satellite contract from DoW
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
